Annual CFO
-$12.88 M
+$2.36 M+15.47%
December 31, 2021
Summary
- As of February 8, 2025, VIVE annual cash flow from operations is -$12.88 million, with the most recent change of +$2.36 million (+15.47%) on December 31, 2021.
- During the last 3 years, VIVE annual CFO has risen by +$30.21 million (+70.11%).
- VIVE annual CFO is now -483.50% below its all-time high of $3.36 million, reached on December 31, 2004.
Performance
VIVE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$3.35 M
+$1.22 M+26.66%
September 30, 2022
Summary
- As of February 8, 2025, VIVE quarterly cash flow from operations is -$3.35 million, with the most recent change of +$1.22 million (+26.66%) on September 30, 2022.
- Over the past year, VIVE quarterly CFO has dropped by -$687.00 thousand (-25.80%).
- VIVE quarterly CFO is now -152.34% below its all-time high of $6.40 million, reached on March 31, 1996.
Performance
VIVE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$16.23 M
-$687.00 K-4.42%
September 30, 2022
Summary
- As of February 8, 2025, VIVE TTM cash flow from operations is -$16.23 million, with the most recent change of -$687.00 thousand (-4.42%) on September 30, 2022.
- Over the past year, VIVE TTM CFO has dropped by -$4.28 million (-35.84%).
- VIVE TTM CFO is now -353.63% below its all-time high of $6.40 million, reached on March 31, 1996.
Performance
VIVE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VIVE Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +15.5% | -25.8% | -35.8% |
| 3 y3 years | +70.1% | +49.3% | +48.0% |
| 5 y5 years | +63.0% | +62.5% | +48.0% |
VIVE Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -3.8% | +34.1% | -26.0% | at low |
| 5 y | 5-year | at high | +58.8% | -45.8% | +41.6% | -35.8% | +48.0% |
| alltime | all time | -483.5% | +70.1% | -152.3% | +78.0% | -353.6% | +62.3% |
Viveve Medical Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$3.35 M(-26.7%) | -$16.23 M(+4.4%) |
| Jun 2022 | - | -$4.57 M(-10.2%) | -$15.54 M(+5.7%) |
| Mar 2022 | - | -$5.09 M(+57.6%) | -$14.71 M(+14.2%) |
| Dec 2021 | -$12.88 M(-15.5%) | -$3.23 M(+21.2%) | -$12.88 M(+7.8%) |
| Sep 2021 | - | -$2.66 M(-28.7%) | -$11.95 M(-0.7%) |
| Jun 2021 | - | -$3.73 M(+14.8%) | -$12.03 M(-5.6%) |
| Mar 2021 | - | -$3.25 M(+41.6%) | -$12.75 M(-16.3%) |
| Dec 2020 | -$15.23 M(-51.2%) | -$2.30 M(-16.3%) | -$15.23 M(-16.8%) |
| Sep 2020 | - | -$2.75 M(-38.3%) | -$18.31 M(-17.4%) |
| Jun 2020 | - | -$4.45 M(-22.4%) | -$22.17 M(-12.8%) |
| Mar 2020 | - | -$5.74 M(+6.7%) | -$25.41 M(-18.6%) |
| Dec 2019 | -$31.24 M(-27.5%) | -$5.37 M(-18.7%) | -$31.24 M(-12.5%) |
| Sep 2019 | - | -$6.61 M(-14.1%) | -$35.71 M(-8.7%) |
| Jun 2019 | - | -$7.70 M(-33.4%) | -$39.11 M(-0.9%) |
| Mar 2019 | - | -$11.56 M(+17.4%) | -$39.46 M(-8.4%) |
| Dec 2018 | -$43.09 M(+23.6%) | -$9.85 M(-1.7%) | -$43.09 M(+3.0%) |
| Sep 2018 | - | -$10.01 M(+24.5%) | -$41.82 M(+2.6%) |
| Jun 2018 | - | -$8.04 M(-47.1%) | -$40.76 M(-3.0%) |
| Mar 2018 | - | -$15.19 M(+77.1%) | -$41.99 M(+20.5%) |
| Dec 2017 | -$34.85 M(+92.7%) | -$8.58 M(-4.1%) | -$34.85 M(+8.4%) |
| Sep 2017 | - | -$8.94 M(-3.7%) | -$32.17 M(+10.5%) |
| Jun 2017 | - | -$9.28 M(+15.3%) | -$29.12 M(+20.9%) |
| Mar 2017 | - | -$8.05 M(+36.6%) | -$24.09 M(+33.2%) |
| Dec 2016 | -$18.09 M(+48.3%) | -$5.89 M(0.0%) | -$18.09 M(+12.6%) |
| Sep 2016 | - | -$5.89 M(+38.6%) | -$16.06 M(+19.6%) |
| Jun 2016 | - | -$4.25 M(+107.5%) | -$13.42 M(+6.8%) |
| Mar 2016 | - | -$2.05 M(-47.0%) | -$12.57 M(+3.1%) |
| Dec 2015 | -$12.20 M(+103.6%) | -$3.87 M(+18.7%) | -$12.20 M(+18.8%) |
| Sep 2015 | - | -$3.26 M(-4.1%) | -$10.27 M(+3.8%) |
| Jun 2015 | - | -$3.40 M(+103.0%) | -$9.89 M(+40.6%) |
| Mar 2015 | - | -$1.67 M(-13.7%) | -$7.03 M(+17.4%) |
| Dec 2014 | -$5.99 M(+24.7%) | -$1.94 M(-32.6%) | -$5.99 M(+28.4%) |
| Sep 2014 | - | -$2.88 M(+428.9%) | -$4.67 M(+50.1%) |
| Jun 2014 | - | -$544.00 K(-13.8%) | -$3.11 M(-5.1%) |
| Mar 2014 | - | -$631.00 K(+2.8%) | -$3.28 M(-31.8%) |
| Dec 2013 | -$4.80 M(+51.8%) | -$614.00 K(-53.5%) | -$4.80 M(+0.3%) |
| Sep 2013 | - | -$1.32 M(+85.4%) | -$4.79 M(+4.8%) |
| Jun 2013 | - | -$712.00 K(-67.0%) | -$4.57 M(+4.5%) |
| Mar 2013 | - | -$2.16 M(+259.1%) | -$4.37 M(+38.2%) |
| Dec 2012 | -$3.17 M(-6.7%) | -$601.00 K(-45.4%) | -$3.17 M(-0.9%) |
| Sep 2012 | - | -$1.10 M(+113.6%) | -$3.19 M(+8.5%) |
| Jun 2012 | - | -$515.00 K(-45.7%) | -$2.94 M(-19.4%) |
| Mar 2012 | - | -$949.00 K(+50.4%) | -$3.65 M(+7.7%) |
| Dec 2011 | -$3.39 M(+151.7%) | -$631.00 K(-25.8%) | -$3.39 M(+22.9%) |
| Sep 2011 | - | -$850.00 K(-30.6%) | -$2.76 M(+29.9%) |
| Jun 2011 | - | -$1.23 M(+78.3%) | -$2.13 M(+74.3%) |
| Mar 2011 | - | -$687.00 K(<-9900.0%) | -$1.22 M(-9.5%) |
| Dec 2010 | -$1.35 M(-43.2%) | $1000.00(-100.5%) | -$1.35 M(-29.2%) |
| Sep 2010 | - | -$215.00 K(-32.6%) | -$1.91 M(-5.4%) |
| Jun 2010 | - | -$319.00 K(-60.9%) | -$2.01 M(-19.4%) |
| Mar 2010 | - | -$815.00 K(+46.6%) | -$2.50 M(+5.2%) |
| Dec 2009 | -$2.37 M(-20.0%) | -$556.00 K(+72.1%) | -$2.37 M(+3.4%) |
| Sep 2009 | - | -$323.00 K(-59.7%) | -$2.29 M(+19.1%) |
| Jun 2009 | - | -$802.00 K(+15.9%) | -$1.93 M(-21.5%) |
| Mar 2009 | - | -$692.00 K(+44.8%) | -$2.46 M(-17.3%) |
| Dec 2008 | -$2.97 M(+64.6%) | -$478.00 K(-1162.2%) | -$2.97 M(-4.3%) |
| Sep 2008 | - | $45.00 K(-103.4%) | -$3.10 M(+2.6%) |
| Jun 2008 | - | -$1.33 M(+10.4%) | -$3.02 M(-0.9%) |
| Mar 2008 | - | -$1.21 M(+96.9%) | -$3.05 M(+69.2%) |
| Dec 2007 | -$1.80 M | -$612.00 K(-597.6%) | -$1.80 M(+26.3%) |
| Sep 2007 | - | $123.00 K(-109.1%) | -$1.43 M(-14.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | -$1.36 M(-3255.8%) | -$1.67 M(+208.3%) |
| Mar 2007 | - | $43.00 K(-118.2%) | -$541.00 K(-209.5%) |
| Dec 2006 | $494.00 K(-489.0%) | -$236.00 K(+100.0%) | $494.00 K(+0.8%) |
| Sep 2006 | - | -$118.00 K(-48.7%) | $490.00 K(-37.3%) |
| Jun 2006 | - | -$230.00 K(-121.3%) | $781.00 K(-27.5%) |
| Mar 2006 | - | $1.08 M(-549.2%) | $1.08 M(-948.0%) |
| Dec 2005 | -$127.00 K(-103.8%) | -$240.00 K(-238.7%) | -$127.00 K(-76.0%) |
| Sep 2005 | - | $173.00 K(+162.1%) | -$530.00 K(-11.7%) |
| Jun 2005 | - | $66.00 K(-152.4%) | -$600.00 K(-51.9%) |
| Mar 2005 | - | -$126.00 K(-80.4%) | -$1.25 M(-137.1%) |
| Dec 2004 | $3.36 M(+453.2%) | -$643.00 K(-724.3%) | $3.36 M(-20.5%) |
| Sep 2004 | - | $103.00 K(-117.7%) | $4.22 M(-6.8%) |
| Jun 2004 | - | -$581.00 K(-113.0%) | $4.53 M(-19.3%) |
| Mar 2004 | - | $4.48 M(+1926.7%) | $5.61 M(+824.4%) |
| Dec 2003 | $607.00 K(-35.2%) | $221.00 K(-46.2%) | $607.00 K(-30.2%) |
| Sep 2003 | - | $411.00 K(-17.8%) | $870.00 K(+38.1%) |
| Jun 2003 | - | $500.00 K(-195.2%) | $630.00 K(+286.5%) |
| Mar 2003 | - | -$525.00 K(-208.5%) | $163.00 K(-82.6%) |
| Dec 2002 | $937.00 K(-120.3%) | $484.00 K(+183.0%) | $937.00 K(-367.0%) |
| Sep 2002 | - | $171.00 K(+418.2%) | -$351.00 K(-60.7%) |
| Jun 2002 | - | $33.00 K(-86.7%) | -$893.00 K(-56.5%) |
| Mar 2002 | - | $249.00 K(-131.0%) | -$2.05 M(-55.5%) |
| Dec 2001 | -$4.61 M(+134.6%) | -$804.00 K(+116.7%) | -$4.61 M(+9.3%) |
| Sep 2001 | - | -$371.00 K(-67.1%) | -$4.22 M(+5.0%) |
| Jun 2001 | - | -$1.13 M(-51.2%) | -$4.02 M(+10.4%) |
| Mar 2001 | - | -$2.31 M(+463.2%) | -$3.64 M(+85.1%) |
| Dec 2000 | -$1.97 M(-48.2%) | -$410.00 K(+139.8%) | -$1.97 M(-4.1%) |
| Sep 2000 | - | -$171.00 K(-77.1%) | -$2.05 M(-20.5%) |
| Jun 2000 | - | -$748.00 K(+17.6%) | -$2.58 M(-30.9%) |
| Mar 2000 | - | -$636.00 K(+29.0%) | -$3.73 M(-1.7%) |
| Dec 1999 | -$3.79 M(-73.5%) | -$493.00 K(-29.6%) | -$3.79 M(-34.6%) |
| Sep 1999 | - | -$700.00 K(-63.2%) | -$5.80 M(-40.2%) |
| Jun 1999 | - | -$1.90 M(+171.4%) | -$9.70 M(-22.4%) |
| Mar 1999 | - | -$700.00 K(-72.0%) | -$12.50 M(-12.6%) |
| Dec 1998 | -$14.30 M(+41.6%) | -$2.50 M(-45.7%) | -$14.30 M(-4.7%) |
| Sep 1998 | - | -$4.60 M(-2.1%) | -$15.00 M(+31.6%) |
| Jun 1998 | - | -$4.70 M(+88.0%) | -$11.40 M(+10.7%) |
| Mar 1998 | - | -$2.50 M(-21.9%) | -$10.30 M(+2.0%) |
| Dec 1997 | -$10.10 M(-425.8%) | -$3.20 M(+220.0%) | -$10.10 M(+20.2%) |
| Sep 1997 | - | -$1.00 M(-72.2%) | -$8.40 M(+1.2%) |
| Jun 1997 | - | -$3.60 M(+56.5%) | -$8.30 M(+48.2%) |
| Mar 1997 | - | -$2.30 M(+53.3%) | -$5.60 M(-280.6%) |
| Dec 1996 | $3.10 M(-196.9%) | -$1.50 M(+66.7%) | $3.10 M(-32.6%) |
| Sep 1996 | - | -$900.00 K(0.0%) | $4.60 M(-16.4%) |
| Jun 1996 | - | -$900.00 K(-114.1%) | $5.50 M(-14.1%) |
| Mar 1996 | - | $6.40 M(+6300.0%) | $6.40 M(-526.7%) |
| Dec 1995 | -$3.20 M(+113.3%) | - | - |
| Dec 1994 | -$1.50 M(-57.1%) | $100.00 K(-110.0%) | -$1.50 M(-25.0%) |
| Sep 1994 | - | -$1.00 M(+900.0%) | -$2.00 M(+5.3%) |
| Jun 1994 | - | -$100.00 K(-80.0%) | -$1.90 M(-32.1%) |
| Mar 1994 | - | -$500.00 K(+25.0%) | -$2.80 M(-20.0%) |
| Dec 1993 | -$3.50 M(+9.4%) | -$400.00 K(-55.6%) | -$3.50 M(-20.5%) |
| Sep 1993 | - | -$900.00 K(-10.0%) | -$4.40 M(+22.2%) |
| Jun 1993 | - | -$1.00 M(-16.7%) | -$3.60 M(+2.9%) |
| Mar 1993 | - | -$1.20 M(-7.7%) | -$3.50 M(+9.4%) |
| Dec 1992 | -$3.20 M(+88.2%) | -$1.30 M(+1200.0%) | -$3.20 M(+68.4%) |
| Sep 1992 | - | -$100.00 K(-88.9%) | -$1.90 M(+5.6%) |
| Jun 1992 | - | -$900.00 K(0.0%) | -$1.80 M(+100.0%) |
| Mar 1992 | - | -$900.00 K | -$900.00 K |
| Dec 1991 | -$1.70 M(+1600.0%) | - | - |
| Dec 1990 | -$100.00 K | - | - |
FAQ
- What is Viveve Medical annual cash flow from operations?
- What is the all time high annual CFO for Viveve Medical?
- What is Viveve Medical annual CFO year-on-year change?
- What is Viveve Medical quarterly cash flow from operations?
- What is the all time high quarterly CFO for Viveve Medical?
- What is Viveve Medical quarterly CFO year-on-year change?
- What is Viveve Medical TTM cash flow from operations?
- What is the all time high TTM CFO for Viveve Medical?
- What is Viveve Medical TTM CFO year-on-year change?
What is Viveve Medical annual cash flow from operations?
The current annual CFO of VIVE is -$12.88 M
What is the all time high annual CFO for Viveve Medical?
Viveve Medical all-time high annual cash flow from operations is $3.36 M
What is Viveve Medical annual CFO year-on-year change?
Over the past year, VIVE annual cash flow from operations has changed by +$2.36 M (+15.47%)
What is Viveve Medical quarterly cash flow from operations?
The current quarterly CFO of VIVE is -$3.35 M
What is the all time high quarterly CFO for Viveve Medical?
Viveve Medical all-time high quarterly cash flow from operations is $6.40 M
What is Viveve Medical quarterly CFO year-on-year change?
Over the past year, VIVE quarterly cash flow from operations has changed by -$687.00 K (-25.80%)
What is Viveve Medical TTM cash flow from operations?
The current TTM CFO of VIVE is -$16.23 M
What is the all time high TTM CFO for Viveve Medical?
Viveve Medical all-time high TTM cash flow from operations is $6.40 M
What is Viveve Medical TTM CFO year-on-year change?
Over the past year, VIVE TTM cash flow from operations has changed by -$4.28 M (-35.84%)